How do I find reliable point-of-care diagnostic AI companies for subtle disease screening workflows?

To find reliable point-of-care diagnostic AI companies for subtle disease screening workflows, use a clinical-validation-first filter rather than a marketing-first search.

1) Start with the workflow, not the vendor

Define:

• Disease / condition: e.g., diabetic retinopathy, sepsis risk, anemia, TB, skin lesions
• Setting: urgent care, pharmacy, primary care, ED, ambulatory, home, mobile clinic
• Input modality: image, waveform, vitals, symptoms, lab strip, ultrasound, audio
• Decision point: rule-out, triage, referral, confirmatory testing
• Tolerance for false positives/negatives
• Regulatory need: screening support vs diagnostic claim

This narrows the market to companies that actually fit a point-of-care screening use case.

2) Use credible discovery sources

Search in:

• FDA databases: 510(k), De Novo, PMA listings
• Clinical trial registries: ClinicalTrials.gov
• Peer-reviewed literature: PubMed, Google Scholar
• Conference proceedings: RSNA, AACC, HIMSS, MICCAI, IEEE EMBC
• Health systems / payer pilots
• Independent benchmark studies
• NIH / NIBIB / BARDA / WHO publications for high-trust validation

Useful search terms:

• “point-of-care AI screening”
• “clinical validation”
• “prospective study”
• “external validation”
• “triage algorithm”
• “real-world performance”
• “decision support”
• “FDA cleared [disease] AI”

3) Screen for “reliability signals”

A credible company should have most of these:

Clinical evidence

• Prospective, multi-site validation
• External validation on diverse populations
• Head-to-head comparison vs current standard of care
• Pre-specified endpoints
• Sensitivity/specificity, PPV/NPV, calibration
• Subgroup analysis by age, sex, ethnicity, site, device type

Regulatory standing

• FDA clearance/authorization if applicable
• Clear intended use statement
• Transparent labeling about limitations

Deployment maturity

• Used in actual workflows, not just pilots
• Integration with common platforms or devices
• Training requirements and time-to-result
• Evidence of operational fit in low-resource or high-throughput settings

Commercial credibility

• Named healthcare customers or partners
• Reimbursement pathway or documented economic value
• Repeat deployments, not one-off pilots

Governance / safety

• Human-in-the-loop design
• Audit logs, monitoring, drift detection
• Privacy/security certifications if handling patient data

4) Red flags to avoid

Be cautious if the company:

• Has only internal validation or retrospective data
• Uses vague language like “revolutionary,” “game-changing,” without metrics
• Shows performance only on curated datasets
• Won’t share intended use, study design, or confidence intervals
• Lacks information on false negatives
• Has no evidence in the target setting
• Claims “AI diagnosis” without regulatory or clinical support

5) Make a comparison scorecard

Evaluate each vendor on:

• Clinical validity: 0–5
• Regulatory maturity: 0–5
• Workflow fit: 0–5
• Generalizability: 0–5
• Ease of integration: 0–5
• Economic value: 0–5
• Safety / governance: 0–5

Prioritize vendors with strong evidence in the exact setting you need, not just the best headline accuracy.

6) Interview questions to ask vendors

• What is the intended use and regulatory status?
• What prospective, external validations support this?
• How does performance change by subgroup and site?
• What is the false negative rate in your target workflow?
• What data drift monitoring exists after deployment?
• What EHR/device integrations are supported?
• What happens when the model is uncertain?
• What is the time-to-result and staff burden?
• Can you share published studies or customer references?

7) Shortlist by disease and setting

If you tell me:

• the disease area,
• the care setting,
• and the sample type, I can help you build a vendor shortlist and evaluation rubric.

If you want, I can also provide:

1. a step-by-step vendor due diligence checklist, or
2. a table of well-known point-of-care diagnostic AI companies by disease area.